Extracorporeal photochemotherapy for graft versus host disease in pediatric patients

Transfusion and Apheresis Science

Volumn 28, Issue 1, 2003, Pages 71-80

  Kanold, Justyna ^a,b   Paillard, Catherine ^b   Halle, Pascale ^a   D'Incan, Michel ^b   Bordigoni, Pierre ^c   Deméocq, François ^a,b  

^a HÔTEL DIEU   (France)

^b Lab Pharmacologie Clin Toxicologie   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Children; Extracorporeal photochemotherapy; GvHD

Indexed keywords

BODY WEIGHT; EXTRACORPOREAL CIRCULATION; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOLOGY; HEMODYNAMICS; HUMAN; HYPOTENSION; IRRADIATION; LEUKAPHERESIS; PHOTOCHEMOTHERAPY; PSYCHOLOGY; REVIEW; TREATMENT OUTCOME;

EID: 0037293169     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-0502(02)00102-7     Document Type: Review

References (38)

1. Ringden O. Allogeneic bone marrow transplantation for hematological malignancies-controversies and recent advances. Acta Oncol. 36:1997;549-564.
2. Peters C, Minkov M, Gadner H, Klingebiel T, Vossen J, Locatelli F, et al. For the European Group for Blood and marrow Transplantation (EBMT) Working Party Paediatric Diseases and the International BFM Study Group-Subcommittee Bone Marrow Transplantation (IBFM-SG). Statement of current majority practices in graft-versus-host disease prophylaxis and treatment in children. Bone Marrow Transpl 2000;26:405-411.
3. Sullivan K.M., Witherspoon R.P., Storb R., Deeg H.J., Dahlberg S., Sandres J.E. et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-versus-host disease. Blood. 72:1988;555-561.
4. Vogelsang G.B. How I treat graft-versus-host disease? Blood. 97:2001;1196-1201.
5. Vogelsang G.B., Farmer E.R., Hess A.D., Altamonte V., Beschorner W.E., Jabs D.A. et al. Thalidomide for the treatment of chronic graft-versus-host disease. New Engl. J. Med. 326:1992;1055-1058.
6. Eppinger T., Ehninger G., Steinfert M., Niethammer D., Dopfer R. 8-Methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host disease. Transplant. 50:1990;807-811.
7. Vogelsang G., Wolff D., Altomonte V., Farmer E., Morison W.L., Corio R. et al. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA). Bone Marrow Transpl. 7:1996;1061-1067.
8. Hervé P., Wijdenes J., Bergerat J.P., Bordigoni P., Milpied N., Cahn J.Y. et al. Treatment of corticoid resistant acute graft-versus-host disease by in vivo administration of antiinterleukin-2 receptor monoclonal antibody (B-B10). Blood. 75:1990;1017-1023.
9. Herbelin C., Stephan J.L., Donadieu J., Le deist F., Racadot E., Wijdenes J. et al. Treatment of steroid resistant acute graft-versus-host disease with an anti-IL-2 receptor monoclonal antibody (BT563) in children who received T cell-depleted, partially matched, related bone marrow transplants. Bone Marrow Transpl. 13:1994;563-569.
10. Przepiorka D., Kernan N.A., Ippoliti C., Papadopoulos E.B., Giralt S., Khouri I. et al. Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease. Blood. 95:2000;83-89.
11. Mookerjee B., Altomonte V., Vogelsang G. Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus. Bone Marrow Transpl. 24:1999;517-520.
12. Kanamaru A., Takemoto Y., Kakishita E., Dony H., Kodera Y., Moriyama Y. et al. FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group. Bone Marrow Transpl. 15:1995;885-889.
13. Greinix H.T., Volc-Platzer B., Kalhs P., Fisher G., Rosenmayr A., Keil F. et al. Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study. Blood. 96:2000;2426-2431.
14. Greinix H.T., Volc-Platzer B., Rabitsch W., Gmeinhart B., Guevara-Pineda C., Kalhs P. et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood. 92:1998;3098-3104.
15. Owsianowski M., Gollnick H., Siegert W., Schwerdtfeger R., Orfanos C.E. Successful treatment of severe chronic graft-versus-host disease with extracorporeal photopheresis. Bone Marrow Transpl. 14:1994;845-848.
16. Bladon J., Taylor P.C. Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients. Br. J. Haem. 107:1999;707-711.
17. Sniecinski I. Extracorporeal photochemotherapy: a scientific overview. Transfus Sci. 15:1994;429-434.
18. Zic J.A., Miller J.L., Stricklin G.P., King L.E. Jr. The North American experience with photopheresis. Ther. Apher. 3:1999;50-62.
19. Child F.J., Ratnavel R., Watkins P., Samson D., Apperley J., Ball J. et al. Extracorporeal photopheresis in the treatment of chronic graft-versus-host disease. Bone Marrow Transpl. 23:1999;881-887.
20. Rossetti F., Zulian F., Dall'Arnico R. et al. Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-versus-host disease. Transplantation. 59:1995;149-151.
21. Rossetti F., Dall'Amico R., Crovetti G., Messina C., Montini G., Dini G. et al. Extracorporeal photochemistry for the treatment of graft-versus-host disease. Bone Marrow Transpl. 18:1996;175-181.
22. Dall'Amico R., Rossetti F., Zulian F., Montini G., Murer L., Andreetta L. et al. Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease. Br. J. Haematol. 97:1997;848-854.
23. Perotti C., Torreta L., Viarengo G., Roveda L., Bernuzzi S., Carbone S. et al. Feasibility and safety of a new technique of extracorporeal photochemotherapy: experience of 240 procedures. Haematologica. 84:1999;237-241.
24. Halle P., Paillard C., D'Incan M., Bordigoni P., Piguet C., De Lumley L. et al. Successful extracorporeal photochemotherapy for chronic graft-versus-host disease in pediatric patients. J. Hematother. Stem Cell Res. 11(3):2002;501-512.
25. D'incan M., Kanold J., Halle P., De Lumley L., Souteyrand P., Demeocq F. Extracorporeal photopheresis as an alternative therapy for drug-resistant graft versus host disease: three cases. Ann. Dermatol. Venereol. 127(2):2000;166-170.
26. Salvaneschi L., Perotti C., Zecca M., Bernuzzi S., Viarengo G., Giorgiani G. et al. Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood. Transfusion. 41(10):2001;1299-1305.
27. Looks A., Fuchs D., Rulke D., Lange D., Zintl F., Wollina U. Successful treatment of acute graft versus host disease after bone marrow transplantation in 16-year-old girl with extracorporeal photopheresis. Onkologie. 20:1997;340-342.
28. Balda B., Kostantinov A., Starz H., Gneklow A., Heidemann P. Extracorporeal photochemotherapy as an effective treatment modality in chronic graft versus host disease. J. Eur. Acad. Dermatol. Venerol. 7:1996;155-162.
29. Besnier D.P., Chabannes D., Mahe B., Mussini J.M., Baranger T.A., Muller J.Y. et al. Treatment of graft-versus-host disease by extracorporeal photochemotherapy: a pilot study. Transplantation. 64(1):1997;49-54.
30. Biagi E., Perseghin P., Buscemi F., Dassi M., Rovelli A., Balduzzi A. Effectiveness of extracorporeal photochemotherapy in treating refractory chronic graft-versus-host disease. Haematologica. 85(3):2000;329-330.
31. Perutelli P., Rivabella L., Lanino E., Pistoia V., Dini G. ATP downregulation in mononuclear cells from children with graft-versus-host disease following extracorporeal photochemotherapy. Haematologica. 87(3):2002;335-336.
32. Perseghin P., Dassi M., Balduzzi A., Rovelli A., Bonanomi S., Uderzo C. Mononuclear cell collection in patients undergoing extra-corporeal photo-chemotherapy for acute and chronic graft vs host disease: comparison between Cobe Spectra version 4.7 and 6.0 (Auto PBSC). J. Clin. Apher. 17:2002;65-71.
33. Glucksbera H., Storb R., Fefer A. et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation. 18:1974;295-304.
34. Shulman H.M., Sullivan K.N.I., Weiden P.L. et al. Chronic graft-versus-host syndrome in man. A long-term clinico-pathologic study of 20 Seattle patients. Am J Med. 69:1980;204-217.
35. Kanold J., Halle P., Rapatel C., Berger M., Gembara P., deLumley L. et al. Safe and efficient peripheral blood stem cell collection in the smallest of children. Ther. Apher. 2(1):1998;49-57.
36. Andreu G., Leon A., Heshmati F., Tod M., Menkes C.J., Baudelot J. et al. Extracorporeal photochemotherapy: evaluation of two techniques and use in connective tissue disorders. Transf. Sci. 15:1994;443-454.
37. Locatelli F., Percivalle E., Comoli P. et al. Human cytomegalovirus infection in pediatric patients given allogeneic bone marrow transplantation: role of early treatment of antigenemia on patients' outcome. Br. J. Haematol. 88:1994;64-71.
38. Schooneman F., Claise C. Treatment of graft versus host disease by photopheresis? Transfus Sci. 17(4):1996;527-536.